Pharma & Biotech News #PharmaBuzz

With Fermion, start the journey of your innovative API.

Weekly News Recap #Phispers

Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn

This week’s Phispers is packed with news of drug approvals and M&As. Merck is preparing for its future post-Keytruda pate...

Impressions : 654

FDA approves J&J's plaque psoriasis pill; federal judge blocks key parts of RFK Jr's childhood vaccine policy overhaul

As the war in the Middle East intensifies, the world is facing disruption of major air and sea routes. The war is already disr...

Impressions : 972

Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

In Phispers this week, Eli Lilly announced its plans to invest US$ 3 billion in China over the next decade in order to build p...

Impressions : 2221

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Over the past week, tensions in the Middle East have escalated sharply after the US and Israel launched military strikes on Ira...

Impressions : 689

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn

FDA approves J&J's plaque psoriasis pill; federal judge blocks key parts of RFK Jr's childhood vaccine policy overhaul

Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Teva's Generics Nintedanib Receives Tentative Approval in US

Glenmark' Generics Nintedanib Receives Tentative Approval in US

Corcept Therap's Lifyorlitm Receives Approval in Us

Encube's Generics Tretinoin Receives Approval in US

Denali's Biologics Avlayah Receives Approval in US

Ascent Pharms' Generics Guanfacine HCl Receives Approval in US

Unique's Generics Bisoprolol Fumarate Receives Approval in US

Zhejiang Jingxin's Generics Ticagrelor Receives Approval in US

Macleods Pharms' Generics Mexiletine HCl Receives Approval in US

Rising's Generics Clindamycin Phosphate Receives Approval in US

4U Health's Receives FDA Warning Letter

Yangzhou H&R Plastic Daily Chemical's Receives FDA Warning Letter

Amneal Issues Voluntary Nationwide Recall of Magnesium Sulfate

Xiamen Kang Zhongyuan Biotech is on FDA Import Alert List

Cardinal Health Issues Voluntary Nationwide Recall of Webcol

Erkul Kozmetik Sanayi is on FDA Import Alert List

Vedic Lifesciences' Receives FDA Warning Letter

OraLabs' Receives FDA Warning Letter

Flowchem Pharma's Receives FDA Warning Letter

Apothecary Pharma's Receives FDA Warning Letter

WINREVAIR Shows Ph2 Proof In PH-HFpEF Patients

BMS Camzyos Shows Ph3 Efficacy In Adolescent oHCM Trial

Lilly Taltz, Zepbound Show Strong PsA, Obesity Efficacy

Repatha Reduces First Major Cardiovascular Event Risk by 31%

Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%

Lilly Embraces AI Biotech Insilico Again, Inking $2.75B Collab

Centre To Enforce 'Essentials' Act For Bulk Drug Price Regulation

N6 Introduces Icon16 For Autonorm In Lower-Throughput NGS

Medical AI Wins First-Ever ACC Digital Health Award

Anumana Gets FDA Nod For AI ECG PH Detection Tool

Alembic Gets USFDA Nod For Paroxetine ER Tablets

IMA Seeks Specialist Rx For GLP-1 Misuse Risks

Lupin Gets Tentative FDA Approval for Pitolisant Tablets

GDUFA IV Talks Tackle DMFs, Consultations as Deadline Looms

Weight Loss Drug Market Sees Surge From Pharma Companies

USV Launches 'Usema' To Address India's Metabolic Health Burden

Novo To Track Generic Surge As Semaglutide Goes Off Patent

Obesity Bet May Drive Focus On Chronic Segment: Alkem Labs

Novo To Track Generic Surge As Semaglutide Goes Off Patent

Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk

WINREVAIR Shows Ph2 Proof In PH-HFpEF Patients

BMS Camzyos Shows Ph3 Efficacy In Adolescent oHCM Trial

Lilly Taltz, Zepbound Show Strong PsA, Obesity Efficacy

Lilly Embraces AI Biotech Insilico Again, Inking $2.75B Collab

N6 Introduces Icon16 For Autonorm In Lower-Throughput NGS

Corcept Presents MOMENTUM Trial Data At ACC Session

Takeda Zasocitinib Shows Durable Skin Clearance In Psoriasis

Moonlake Reveals Phase 3 Sonelokimab Trial Results

Vivoryon Updates Glutaminyl Cyclases As Key Targets In DKD

Takeda Clears Path To FDA With Phase 3 Data On $4B Psoriasis Bet

Centre To Enforce 'Essentials' Act For Bulk Drug Price Regulation

EMA finalizes guideline on chemistry of active substances

Key Chemical Costs Hinder Drug Ingredient Makers' Production

Piramal Pharma Solutions Marks 20Th Anniversary With Korsch X3

Cambrex Advances US And European Expansions

Wilmington Launches $50M Expansion To Double API Capacity

Drugmakers Seek Price Caps Amid West Asia Conflict Cost Surge

LGM Pharma Invests $15M in Texas, Colorado Facilities

Axplora Invests $60 Million in HPAPI Expansion at Farmabios Site

Propane Shortage Hits Indian Pharma, Endangering Vitamin Output

Regulator Steps Up Oversight Of GLP-1 Drug Distribution Chain

Telangana DCA Issues Safety Advisory On Use Of Semaglutide

Novartis Sued Over Third-Party Data Sharing From Branded Sites

Centre Enhances GLP-1 Drug Oversight Due To Concerns Practices

CSL adds warning to Flucelvax label

GAO calls on FDA to finalize guidance on adcomm COI

DCGI Intensifies Crackdown on GLP-1 Drug Misuse, Misleading Ads

Government Enhances Oversight On Unauthorized GLP-1 Sales

Immunitybio Hit With FDA Warning Letter Over Anktiva Promotions

Lilly Plots European Discontinuations Of Certain Insulin Products

Repatha Reduces First Major Cardiovascular Event Risk by 31%

Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%

Medical AI Wins First-Ever ACC Digital Health Award